Literature DB >> 21516407

Isolation and culture of ovarian cancer cells and cell lines.

Christian M Kurbacher1, Cornelia Korn, Susanne Dexel, Ulrike Schween, Jutta A Kurbacher, Ralf Reichelt, Petra N Arenz.   

Abstract

Ovarian carcinomas show considerable heterogeneity of origin, both in terms of site and tissue. The most important and also most frequent of these tumors arise from the coelomic epithelium and are therefore characterized as epithelial ovarian carcinomas (EOC). EOC is often large and advanced at the time of presentation, so that cells are readily obtainable from surgical specimens or effusions. While the primary tumor may be chemosensitive, they often develop resistance and may do so rapidly. Due to the easy access to tumor cells and its biological behavior, EOC is considered to be an ideal model to investigate principal mechanisms of both antineoplastic drug sensitivity and resistance. Although studies on primary EOC cells are now preferred for many of these investigations, EOC cell line studies remain important too. This chapter gives an overview over major techniques required to establish and maintain primary EOC cell cultures and to initiate and cultivate permanently growing EOC cell lines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21516407     DOI: 10.1007/978-1-61779-080-5_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  C/EBPβ promotes poly(ADP-ribose) polymerase inhibitor resistance by enhancing homologous recombination repair in high-grade serous ovarian cancer.

Authors:  Jiahong Tan; Xu Zheng; Mengchen Li; Fei Ye; Chunyan Song; Cheng Xu; Xiaoxue Zhang; Wenqian Li; Ya Wang; Shaoqing Zeng; Huayi Li; Gang Chen; Xiaoyuan Huang; Ding Ma; Dan Liu; Qinglei Gao
Journal:  Oncogene       Date:  2021-05-08       Impact factor: 9.867

2.  Presence of both Mesenchymal and Carcinomatous Features in an In-vitro Model of Ovarian Carcinosarcoma Derived from Patients' Ascitic Fluid.

Authors:  Ahmad Shariftabrizi; Ilenia Pellicciotta; Amer Abdullah; Charis Anne Venditti; Robert Samuelson; Shohreh Shahabi
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2015-01-01

3.  ADAM17 inhibition enhances platinum efficiency in ovarian cancer.

Authors:  Nina Hedemann; Christoph Rogmans; Susanne Sebens; Daniela Wesch; Manuel Reichert; Dirk Schmidt-Arras; Hans-Heinrich Oberg; Ulrich Pecks; Marion van Mackelenbergh; Jörg Weimer; Norbert Arnold; Nicolai Maass; Dirk O Bauerschlag
Journal:  Oncotarget       Date:  2018-03-23

4.  High Antitumor Activity of the Dual Topoisomerase Inhibitor P8-D6 in Breast Cancer.

Authors:  Inken Flörkemeier; Tamara N Steinhauer; Nina Hedemann; Jörg Paul Weimer; Christoph Rogmans; Marion T van Mackelenbergh; Nicolai Maass; Bernd Clement; Dirk O Bauerschlag
Journal:  Cancers (Basel)       Date:  2021-12-21       Impact factor: 6.639

5.  Newly developed dual topoisomerase inhibitor P8-D6 is highly active in ovarian cancer.

Authors:  Inken Flörkemeier; Tamara N Steinhauer; Nina Hedemann; Magnus Ölander; Per Artursson; Bernd Clement; Dirk O Bauerschlag
Journal:  Ther Adv Med Oncol       Date:  2021-11-25       Impact factor: 8.168

6.  A systematic comparison of the anti-tumoural activity and toxicity of the three Adv-TKs.

Authors:  Qinglei Gao; Caihong Chen; Teng Ji; Peng Wu; Zhiqiang Han; Haiyan Fang; Fei Li; Yi Liu; Wencheng Hu; Danni Gong; Zeyu Zhang; Shixuan Wang; Jianfeng Zhou; Ding Ma
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.